The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2026

Filed:

Dec. 20, 2021
Applicant:

The U.s.a, As Represented BY the Secretary, Department of Health and Human Services, Silver Spring, MD (US);

Inventors:

Xiaoming Xu, Columbia, MD (US);

Deval Patel, Frederick, MD (US);

Ying Zhang, Centreville, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/15 (2006.01); B01D 15/08 (2006.01); B01D 61/14 (2006.01); B01D 63/02 (2006.01); G01N 30/14 (2006.01); G01N 30/74 (2006.01); G01N 30/02 (2006.01);
U.S. Cl.
CPC ...
G01N 33/15 (2013.01); B01D 15/08 (2013.01); B01D 61/14 (2013.01); B01D 63/02 (2013.01); G01N 30/14 (2013.01); G01N 30/74 (2013.01); B01D 2315/10 (2013.01); B01D 2315/16 (2013.01); G01N 2030/027 (2013.01); G01N 2030/146 (2013.01);
Abstract

An in vitro release test (IVRT) method and system is provided for drug release testing. The IVRT method, referred to herein as adaptive perfusion, employ tangential-flow filtration (TFF), where released drug products that are smaller than a molecular weight cutoff (MWCO) of a membrane filter pass therethrough into the permeate. Unreleased drug products are retained by the pores of the filter and are recirculated to a retentate reservoir. Fresh media is provided to the retentate in order to maintain a constant total volume for the sample as well as to maintain sink conditions for the drug release. Drug concentration in the retentate and permeate are evaluated by in situ monitoring with one or more sensors and/or by periodic removal of aliquots from the respective reservoirs. In some embodiments, the membrane filter can be conditioned prior to use in order to improve the accuracy, precision, or both of the subsequent testing.


Find Patent Forward Citations

Quick Actions:

Xu, Xiaoming. (2026). Adaptive perfusion systems and methods for drug release testing (U.S. Patent No. 12775001). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12775001

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…